PubMed:24403068 / 0-373 JSONTXT

{"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":154,"end":172},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000988"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T1","span":{"begin":108,"end":282},"obj":"DRI_Background"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":107},"obj":"Sentence"},{"id":"T2","span":{"begin":108,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":327,"end":338},"obj":"http://purl.obolibrary.org/obo/MAT_0000084"},{"id":"T2","span":{"begin":327,"end":331},"obj":"http://purl.obolibrary.org/obo/MAT_0000299"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":0,"end":22},"obj":"gene:5552"},{"id":"T1","span":{"begin":39,"end":55},"obj":"disease:C0026764"},{"id":"T2","span":{"begin":141,"end":150},"obj":"gene:5552"},{"id":"T3","span":{"begin":254,"end":274},"obj":"disease:C0026764"},{"id":"T4","span":{"begin":298,"end":307},"obj":"gene:5552"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":254,"end":270},"obj":"HP_0006775"},{"id":"T2","span":{"begin":339,"end":348},"obj":"HP_0002835"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"Allie","denotations":[{"id":"SS1_24403068_1_0","span":{"begin":254,"end":270},"obj":"expanded"},{"id":"SS2_24403068_1_0","span":{"begin":272,"end":274},"obj":"abbr"}],"relations":[{"id":"AE1_24403068_1_0","pred":"abbreviatedTo","subj":"SS1_24403068_1_0","obj":"SS2_24403068_1_0"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"24403068-0#0#22#gene5552","span":{"begin":0,"end":22},"obj":"gene5552"},{"id":"24403068-0#39#55#diseaseC0026764","span":{"begin":39,"end":55},"obj":"diseaseC0026764"}],"relations":[{"id":"0#22#gene555239#55#diseaseC0026764","pred":"associated_with","subj":"24403068-0#0#22#gene5552","obj":"24403068-0#39#55#diseaseC0026764"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Disease"},{"id":"T2","span":{"begin":254,"end":270},"obj":"Disease"},{"id":"T3","span":{"begin":272,"end":274},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Phenotype"},{"id":"T2","span":{"begin":254,"end":270},"obj":"Phenotype"},{"id":"T3","span":{"begin":272,"end":274},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0006775"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0006775"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0006775"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Disease"},{"id":"T2","span":{"begin":254,"end":270},"obj":"Disease"},{"id":"T3","span":{"begin":272,"end":274},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"GlyCosmos15-CL","denotations":[{"id":"T1","span":{"begin":154,"end":172},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000988"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":154,"end":172},"obj":"Body_part"},{"id":"T2","span":{"begin":327,"end":338},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL_0000988"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":327,"end":338},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000084"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":107},"obj":"Sentence"},{"id":"T2","span":{"begin":108,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":107},"obj":"Sentence"},{"id":"T2","span":{"begin":108,"end":282},"obj":"Sentence"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":327,"end":338},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000084"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":154,"end":172},"obj":"Body_part"},{"id":"T2","span":{"begin":327,"end":338},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL_0000988"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}

{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Phenotype"},{"id":"T2","span":{"begin":254,"end":270},"obj":"Phenotype"},{"id":"T3","span":{"begin":272,"end":274},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0006775"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0006775"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0006775"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly"}